Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
andreessen-horowitz
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
benevolentai
big data
biotech
bluebird bio
boston
boston blog main
boston top stories
business
clinical trials
cloud
duchenne muscular dystrophy
dyne therapeutics
enterprise
entrepreneur
europe
facioscapulohumeral muscular dystrophy
funding daily
gene therapy
joshua brumm
kaleido biosciences
life sciences
mobile
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
os fund
rare disease drugs
romesh subramanian
san diego blog main
san francisco blog main
softbank ventures
susanna high
tc
What
drug
3
×
early
3
×
medicines
3
×
data
discovery
founded
million
raised
stage
accelerate
accelerating
achieve
actually
ago
alto
andreessen
artificial
astrazeneca
benevolentai
biopharmaceutical
biotechs
braintree
bryan
capital
clinical
collaboration
company
considering
develop
development
diseases
dyne
expected
experimental
eyes
facili
firm
focuses
founder
fund
Language
unset
Current search:
early
×
drug
×
medicines
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@techcrunch.com
5 years ago
BenevolentAI starts AI collaboration with AstraZeneca to accelerate drug discovery
@venturebeat.com
6 years ago
TwoXar raises $10 million from SoftBank, Andreessen Horowitz, and OS Fund to grow its AI drug discovery platform
